Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
- Posted on June 1, 2026
- By Usa Today
- 0 Views
- 1 min read
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who can get it.
